Indeed, BM aspirates from MM patients indicated that the canonical adenosinergic CD39/CD73 pathway is flanked by another set of ectoenzymes, which in vivo leads to the production of ADO, this time using NAD+ as the starting substrate (2). Here, ENTPD1 is linked to Miyoshi myopathy.